KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Change in Inventory (2021 - 2025)

Historic Change in Inventory for QuidelOrtho (QDEL) over the last 5 years, with Q3 2025 value amounting to $39.1 million.

  • QuidelOrtho's Change in Inventory rose 14904.46% to $39.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $164.9 million, marking a year-over-year decrease of 657.22%. This contributed to the annual value of $134.1 million for FY2024, which is 3662.57% down from last year.
  • According to the latest figures from Q3 2025, QuidelOrtho's Change in Inventory is $39.1 million, which was up 14904.46% from $49.5 million recorded in Q2 2025.
  • QuidelOrtho's Change in Inventory's 5-year high stood at $65.6 million during Q4 2023, with a 5-year trough of -$21.5 million in Q4 2021.
  • For the 5-year period, QuidelOrtho's Change in Inventory averaged around $34.4 million, with its median value being $38.4 million (2024).
  • As far as peak fluctuations go, QuidelOrtho's Change in Inventory skyrocketed by 31560.69% in 2023, and later plummeted by 7383.33% in 2024.
  • QuidelOrtho's Change in Inventory (Quarter) stood at -$21.5 million in 2021, then rose by 19.53% to -$17.3 million in 2022, then surged by 479.19% to $65.6 million in 2023, then tumbled by 64.63% to $23.2 million in 2024, then skyrocketed by 68.53% to $39.1 million in 2025.
  • Its Change in Inventory stands at $39.1 million for Q3 2025, versus $49.5 million for Q2 2025 and $53.1 million for Q1 2025.